Background Gerald P. Bodey (1934−2020) was a pioneering haematologist who revolutionized the management of infectious complications in patients with haematological malignancies. Over 4 decades, he authored >800 peer-reviewed publications and established evidence-based practices that continue to save lives worldwide. Objectives To examine Bodey's seminal contributions to infectious diseases in immunocompromised hosts and their enduring impact on contemporary cancer care. Sources Beginning with his seminal paper on the relationship between infections and circulating neutrophils, this review synthesizes Dr. Bodey's research accomplishments from the 1960s through 2000s, organising his work into chronologically arranged principles that shaped modern oncology practice. Content Seven key principles emerge from Bodey's work: (1) the critical importance of autopsy data for understanding infection epidemiology; (2) quantitative risk assessment using neutrophil counts, establishing the 500 cells/mm3 threshold for empirical antibiotic therapy; (3) timely empirical antibiotic therapy in febrile neutropenic patients; (4) the necessity of studying antibiotics specifically in neutropenic populations; (5) environmental control strategies and prophylaxis; (6) recognition of fungal infections as persistent threats; and (7) mentorship and academic excellence in developing future leaders. Implications Bodey's foundational work established the framework for modern infection management in cancer patients. His quantitative approach to infection risk assessment and empirical antibiotic therapy became standard care for >5 decades. As cancer treatment evolves toward targeted therapies with novel immunosuppressive effects, Bodey's principles require adaptation but remain fundamentally relevant. His legacy demonstrates the importance of rigorous clinical research, mentorship, and patient-focused care in advancing medical knowledge and improving outcomes.
On the shoulders of a giant: an appraisal of the legacy of Dr. Gerald P Bodey to infectious diseases
Lewis R. E.Writing – Original Draft Preparation
;
2025
Abstract
Background Gerald P. Bodey (1934−2020) was a pioneering haematologist who revolutionized the management of infectious complications in patients with haematological malignancies. Over 4 decades, he authored >800 peer-reviewed publications and established evidence-based practices that continue to save lives worldwide. Objectives To examine Bodey's seminal contributions to infectious diseases in immunocompromised hosts and their enduring impact on contemporary cancer care. Sources Beginning with his seminal paper on the relationship between infections and circulating neutrophils, this review synthesizes Dr. Bodey's research accomplishments from the 1960s through 2000s, organising his work into chronologically arranged principles that shaped modern oncology practice. Content Seven key principles emerge from Bodey's work: (1) the critical importance of autopsy data for understanding infection epidemiology; (2) quantitative risk assessment using neutrophil counts, establishing the 500 cells/mm3 threshold for empirical antibiotic therapy; (3) timely empirical antibiotic therapy in febrile neutropenic patients; (4) the necessity of studying antibiotics specifically in neutropenic populations; (5) environmental control strategies and prophylaxis; (6) recognition of fungal infections as persistent threats; and (7) mentorship and academic excellence in developing future leaders. Implications Bodey's foundational work established the framework for modern infection management in cancer patients. His quantitative approach to infection risk assessment and empirical antibiotic therapy became standard care for >5 decades. As cancer treatment evolves toward targeted therapies with novel immunosuppressive effects, Bodey's principles require adaptation but remain fundamentally relevant. His legacy demonstrates the importance of rigorous clinical research, mentorship, and patient-focused care in advancing medical knowledge and improving outcomes.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
